Analyst Sees This Kidney Disease Company's Stock Could Rise Sixfold, But Lists Two Issues
November 18, 2022 at 06:43 AM EST
Piper Sandlerraised its price target onArdelyx Inc(NASDAQ: ARDX) to $8 from $3 and upgraded toOverweight from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.